| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Common Stock | Options Exercise | $712,988 | +6,999 | +33% | $101.87 | 28,000 | 25 Feb 2025 | Direct | |
| transaction | JNJ | Common Stock | Sale | $1,160,994 | -6,999 | -25% | $165.88 | 21,001 | 25 Feb 2025 | Direct | F1 |
| holding | JNJ | Common Stock | 620 | 25 Feb 2025 | By 401k | F2 | |||||
| holding | JNJ | Common Stock | 134 | 25 Feb 2025 | By ESOP | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | $712,988 | -6,999 | -100% | $101.87 | 0 | 25 Feb 2025 | Common Stock | 6,999 | $101.87 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $165.88 to $165.895. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025). |
| F3 | Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025). |
| F4 | Vested and exercisable on the third anniversary of the date of the grant. |